Futures Up, Dell Fl...
Health Care: Drugs
Biosante Pharmaceuticals Inc. (BPAX: NASDAQ)
$1.14 -0.01 | -0.87%
05/17/13 - 03:59 PM ET
Portfolios with BPAX
- Portfolio NameUser Type
- ContributorStocks Under-$10 Setting Up...
- ContributorStocks Under-$10 Moving Hig...
- ContributorStocks Under-$10 Moving Hig...
- ContributorHot Biotech Stocks Traded b...
- UserSaveyn walter
- User2012_03
- Userwayne120
- ContributorBreakout Stocks Of The Week...
- UserDunDon1
- Contributor6 Drug Stocks Unworthy of B...
Latest BPAX Headlines from TheStreet
- The Worst Biotech CEO of 2012 Is... 12.07.12 | 09:12 am
- Your Vote Counts: Who Is the Worst Biotech CEO of 2012? 12.04.12 | 08:12 am
- The Next Big Thing In Biotech: Worst CEO Candidates
11.23.12 | 05:11 am - 4 Biotech Stocks Under $10 Soaring Higher 09.25.12 | 02:09 pm
- 5 Biotech Stocks Under $5 Blasting Off 08.16.12 | 03:08 pm
- BioSante Execs Use Failed Libigel To Keep Paychecks Rolling In 06.11.12 | 09:06 am
- Biosante Stock Gaps Down On Today's Open (BPAX) 06.01.12 | 09:06 am
- Biotech Twitter Mailbag: Gilead, Chelsea, Keryx, Onyx, BioSante, Dendreon 02.29.12 | 06:02 am
- Transocean, Netflix, BioSante Are Market Movers 02.27.12 | 05:02 pm
- Biotech Stock Mailbag: Vivus, Chelsea, BioCryst 02.17.12 | 05:02 am
Press Releases for BPAX
- Ceregene Reports Data From Parkinson's Disease Phase 2b Study - PR Newswire 04.19.13 | 02:04 pm
- BioSante Pharmaceuticals, Inc. Sends Letter Urging Stockholders To Vote “FOR” Proposed Merger With ANI Pharmaceuticals, Inc. - Business Wire 03.19.13 | 09:03 am
- BioSante Pharmaceuticals Announces Adjournment Of Its Stockholders Meeting Until April 12, 2013 - Business Wire 03.15.13 | 04:03 pm
- Ceregene And Alzheimer's Disease Cooperative Study Group Complete Enrollment Of CERE-110 Phase 2 Trial - PR Newswire 03.13.13 | 07:03 am
- Glass, Lewis & Co., LLC Recommends Vote “FOR” BioSante/ANI Merger - Business Wire 03.04.13 | 09:03 am
- BioSante Pharmaceuticals Provides Merger Update And Reports 2012 Financial Results - Business Wire 03.01.13 | 09:03 am
- Leading Independent Proxy Advisory Firm ISS Joins Egan-Jones In Recommending “FOR” BioSante/ANI Merger - Business Wire 02.26.13 | 09:02 am
- Egan-Jones Proxy Services Recommends Stockholders Vote “FOR” BioSante And ANI Merger - Business Wire 02.19.13 | 09:02 am
- BioSante Pharmaceuticals And ANI Pharmaceuticals Announce Special Meetings Of Stockholders To Consider Proposed Merger - Business Wire 01.22.13 | 04:01 pm
- BioSante Pharmaceuticals Reports Third Quarter Financial Results And Merger Update - Business Wire 11.08.12 | 04:11 pm
Partner Headlines for BPAX
- Under Construction Rehash: Buy Acadia And Astex - Seeking Alpha 09.20.12 | 09:09 am
- 5 BioPharmas To Watch For Wednesday, September 5 - Seeking Alpha 09.05.12 | 09:09 am
- Healthcare Biz Recap: Complete Genomics CUTS Costs, Abbott Labs Teams Up - Wall St. Cheat Sheet 06.06.12 | 08:06 am
- Alimera Sciences: An Upcoming Catalyst Should Make For A Nice Stock Gain - Seeking Alpha 03.26.12 | 09:03 am
- Bio-Pharma Watch List: 2 Week Report Card - Seeking Alpha 03.12.12 | 09:03 am
- What BioSante's Balance Sheet Says About Future R&D - Seeking Alpha 03.01.12 | 08:03 am
- 12 Healthcare Companies Expecting Major February Catalysts - Seeking Alpha 02.01.12 | 07:02 am
- 3 Biotechs Hopefully To Get Rich Or Die Trying - Seeking Alpha 01.04.12 | 08:01 am
- Singular Research Drops Coverage on BioSante Pharma After LibGel Results - Benzinga 12.16.11 | 04:12 pm
- Singular Research Reiterates BioSante Pharmaceuticals Buy, Maintains PT - Benzinga 12.13.11 | 01:12 pm
